lysophosphatidylcholine作为亲肠道单克隆抗体配方的界面稳定剂
Eleni Papadopoulos1, Betharie Cendera Arrahmani2, Katharina Beck3
1Ludwig-Maximilians-Universität München, Department of Pharmacy, Pharmaceutical Technology and Biopharmaceutics, Butenandtstraße 5-13 B, 81377 Munich, Germany.
概括
lysophosphatidylcholines (LPCs) 显示出作为治疗性蛋白质配方的替代表面活性剂的希望. 它们有效地防止在机械应力下单克隆抗体颗粒的形成,类似于聚酸盐.
科学领域:
- 制药科学 制药科学
- 生物化学 生物化学
- 材料科学 材料科学 材料科学
背景情况:
- 治疗性蛋白质需要在水溶液中稳定,以防止聚合和颗粒形成.
- 聚酸盐和酸盐是常见的表面活性剂,但聚酸盐可以降解,导致不稳定性和蛋白质氧化.
- 与聚酸盐相比,波洛克萨默在防止蛋白质聚合方面效果较差.
研究的目的:
- 研究 lysophosphatidylcholines (LPCs) 作为蛋白质配方的替代表面活性剂.
- 评估LPCs对单克隆抗体 (mAb) 粒子形成的物理化学行为和保护能力.
- 评估LPCs在血液溶解活性方面的安全概况.
主要方法:
- 经过测试的mAb配方中的LPC受到机械应力 (震动,周围静止) 的影响.
- 在血缓冲混合物中评估LPCs的溶血活性.
- 使用的分析方式包括张力测量,扩展性脊髓学,多角度光散射和异热定位热量测量.
- 通过子相交换实验,评估表面活性剂的脱落和再吸收动态.
主要成果:
- 在机械应力过程中,LPCs有效地稳定了mAb配方,防止粒子形成,可与聚酸盐80和波洛克萨默188.8相比.
- 稳定所需的LPC度明显低于导致血液溶解的水平,这表明安全性概况有利.
- 稳定性归因于在临界微粒度 (CMC) 时形成粘弹性膜.
- LPCs被证明迅速重新吸收到散装溶液中,防止蛋白质吸附到接口.
结论:
- lysophosphatidylcholines (LPCs) 是治疗性蛋白质配方的有效稳定剂,可以防止在机械应力下形成颗粒.
- 在有效度下,LPCs表现出良好的安全性,具有最小的溶血活性.
- 由于它们的界面稳定性,LPCs在亲肠道蛋白质配方中显示出作为聚酸盐可行的替代品的潜力.
关键词:
辅助物质 辅助物质 辅助物质液体-空气接口 液体空气接口莱索-酸胆是一种酸.亲肠道配方可以使用.粒子形成的过程聚酸盐的降解降解蛋白质聚合蛋白质的聚合.蛋白质稳定 蛋白质稳定治疗性蛋白质 治疗性蛋白质更多相关视频
08:01Synthesis of Monocyte-targeting Peptide Amphiphile Micelles for Imaging of Atherosclerosis
Published on: November 17, 2017
7.3K
10:58SNARE-mediated Fusion of Single Proteoliposomes with Tethered Supported Bilayers in a Microfluidic Flow Cell Monitored by Polarized TIRF Microscopy
Published on: August 24, 2016
10.8K
相关概念视频
Synthesis of Phosphatidylcholine in the ER Membrane
3.0K
The ER synthesizes lipids for building cell membranes and performing cellular functions such as energy storage and signaling. The lipid synthesis machinery embedded in the ER membrane primarily collects all reactants from the cytosol. Following synthesis, the secretory pathway and the ER contact sites distribute these lipids to other cellular organelles. Additionally, the energy-rich triacylglycerides are transported from the ER via lipid droplets.
The major components of all eukaryotic cell...
The major components of all eukaryotic cell...
3.0K
Asymmetric Lipid Bilayer
7.2K
Biological membranes show uneven distribution of different types of lipids in the inner and outer layers, resulting in transverse asymmetric membranes. The treatment of the erythrocyte membrane with the enzyme phospholipase confirmed the asymmetric nature of the lipid bilayer. The enzyme hydrolyzes lipids into fatty acids and hydrophilic groups. The phospholipase acts only on the outer layer of the membrane, while the inner layer remains intact. The phospholipase treatment resulted in 80%...
7.2K
Membrane Fluidity
11.0K
Membrane fluidity is explained by the fluid mosaic model of the cell membrane, which describes the plasma membrane structure as a mosaic of components—including phospholipids, cholesterol, proteins, and carbohydrates—that gives the membrane a fluid character.
Mosaic nature of the membrane
The mosaic characteristic of the membrane helps the plasma membrane remain fluid. The integral proteins and lipids exist as separate but loosely-attached molecules in the membrane. The membrane is...
Mosaic nature of the membrane
The mosaic characteristic of the membrane helps the plasma membrane remain fluid. The integral proteins and lipids exist as separate but loosely-attached molecules in the membrane. The membrane is...
11.0K
